Equillium's Registration Statement Declared Effective by SEC
Ticker: EQ · Form: EFFECT · Filed: Mar 26, 2026 · CIK: 0001746466
Complexity: simple
Sentiment: neutral
Topics: registration-statement, capital-raise, regulatory-filing
TL;DR
**Equillium's offering is now effective, clearing the way for potential capital raise.**
AI Summary
Equillium, Inc. (CIK: 0001746466) received notice of effectiveness for its filing (File No.: 333-291510) on March 25, 2026, as indicated by the SEC's acceptance on March 26, 2026. This means the SEC has declared a previously filed registration statement effective, allowing Equillium to proceed with the offering described in that statement. For investors, this is a procedural step that clears the way for potential capital raises, which could impact share dilution or provide funds for operations and drug development.
Why It Matters
This filing signals that Equillium, Inc. can now move forward with a previously proposed securities offering, which could either dilute existing shares if new shares are issued or provide crucial funding for its pharmaceutical operations.
Risk Assessment
Risk Level: medium — While a procedural step, the underlying offering could involve dilution or significant capital infusion, both carrying medium-term risks and opportunities for investors.
Analyst Insight
Investors should review the underlying registration statement (File No.: 333-291510) to understand the specifics of the offering (e.g., type of securities, potential dilution, use of proceeds) before making any investment decisions.
Key Numbers
- 2026-03-25 — Effectiveness Date (The date the SEC declared the registration statement effective, allowing Equillium to proceed with its offering.)
- 333-291510 — File No. (The specific identification number for the registration statement that has been declared effective.)
Key Players & Entities
- Equillium, Inc. (company) — the filer of the EFFECT notice
- 0001746466 (company) — Equillium, Inc.'s CIK number
- 333-291510 (dollar_amount) — the File Number for the registration statement declared effective
- March 25, 2026 (person) — the effectiveness date of the filing
- March 26, 2026 (person) — the acceptance date of the filing by the SEC
Forward-Looking Statements
- Equillium, Inc. will likely proceed with a capital raise or securities offering in the near future. (Equillium, Inc.) — high confidence, target: 2026-06-25
FAQ
What is the primary purpose of an EFFECT filing for Equillium, Inc.?
The primary purpose of this EFFECT filing is to notify the public that the SEC has declared a previously submitted registration statement (File No.: 333-291510) effective. This means Equillium, Inc. can now legally proceed with the offering described in that registration statement.
When was the effectiveness date for Equillium, Inc.'s filing?
The effectiveness date for Equillium, Inc.'s filing was March 25, 2026, as stated in the document.
What is Equillium, Inc.'s CIK number and business address according to this filing?
Equillium, Inc.'s CIK number is 0001746466, and its business address is 2223 AVENIDA DE LA PLAYA SUITE 105, LA JOLLA CA 92037, as detailed in the filing.
What type of industry does Equillium, Inc. operate in, based on its SIC code?
Based on its SIC code 2834, Equillium, Inc. operates in the Pharmaceutical Preparations industry, as indicated in the filing.
What is the significance of the 'Accepted 2026-03-26 00:15:03' timestamp in this filing?
The 'Accepted 2026-03-26 00:15:03' timestamp indicates when the SEC officially accepted and processed this specific EFFECT notice, which followed the actual effectiveness date of March 25, 2026.
Filing Stats: 32 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2026-03-26 00:15:03
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-000928.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 25, 2026 4:01 P.M. Form: S-3 CIK: Company Name: Equillium, Inc. File Number: 333-291510